Tuberculosis remains one of the most consequential infectious disease challenges of our era, and understanding its true trajectory matters enormously as global health funding faces unprecedented cuts. This landmark analysis arrives at a critical juncture: if baseline trends are not accurately documented now, measuring the damage from funding disruptions will be impossible — and WHO's ambitious End TB targets may quietly fail without anyone noticing.
Drawing on the Global Burden of Disease Study 2023, this systematic analysis quantified TB mortality, morbidity, and disability-adjusted life-years (DALYs) across 204 countries and territories from 1990 through 2023. Researchers used the Cause of Death Ensemble modeling platform integrating vital registration, surveillance, verbal autopsy, and minimally invasive tissue sampling data. Incidence, prevalence, and mortality were co-modeled by age and sex using DisMod-MR 2.1, then stratified by HIV co-infection and drug-resistance status using population attributable fractions. Risk factor contributions from alcohol use, smoking, and elevated fasting plasma glucose were also quantified via comparative risk assessment, enabling a granular understanding of modifiable upstream drivers. The scope and methodological rigor place this among the most comprehensive TB burden assessments to date.
For health-conscious readers, the implications extend beyond infectious disease specialists. TB's intersection with metabolic risk factors — particularly hyperglycemia — connects it directly to the broader chronic disease landscape most adults navigate daily. The MDR-TB findings are especially significant: progress toward WHO's 2035 targets appears deeply uneven, with drug-resistant strains representing a disproportionate and growing share of the remaining burden in specific regions. This is a confirmatory-yet-alarming study rather than a paradigm shift — it validates concerns long held by TB researchers while providing the most precise georeferenced evidence yet. The major limitation is the reliance on modeled estimates in settings with weak vital registration. Still, the 33-year longitudinal sweep across nearly every nation makes this an essential reference for evaluating any future policy response.